{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:55:03Z","timestamp":1740135303371,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Opsoclonus-myoclonus syndrome (OMS) is a rare, immune-mediated neurological disorder. In adults, the pathogenesis can be idiopathic, post-infectious or paraneoplastic, the latter etiology belonging to the ever-expanding group of defined paraneoplastic neurological syndromes (PNS). In contrast to other phenotypes of PNS, OMS cannot be ascribed to a single pathogenic autoantibody. Here, we report the first detailed case of paraneoplastic, antibody-negative OMS occurring in association with a pancreatic neuroendocrine tumor (pNET).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 33-year-old female presented with a two-week history of severe ataxia of stance and gait, dysarthria, head tremor, myoclonus of the extremities and opsoclonus. Her past medical history was notable for a metastatic pancreatic neuroendocrine tumor, and she was subsequently diagnosed with paraneoplastic opsoclonus-myoclonus syndrome. Further workup did not reveal a paraneoplastic autoantibody. She responded well to plasmapheresis, as she was refractory to the first-line therapy with corticosteroids.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case expands current knowledge on tumors associated with paraneoplastic opsoclonus-myoclonus syndrome and the age group in which it can occur. It further adds evidence to the effectiveness of plasmapheresis in severe cases of opsoclonus-myoclonus syndrome with a lack of response to first-line therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-03012-6","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T04:29:22Z","timestamp":1672374562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8852-7234","authenticated-orcid":false,"given":"Raphael","family":"Reinecke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemarie","family":"Reil\u00e4nder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Seiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Voss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"key":"3012_CR1","first-page":"1598","volume":"69","author":"JP Klaas","year":"2012","unstructured":"Klaas JP, Ahlskog JE, Pittock SJ, Matsumoto JY, Aksamit AJ, Bartleson JD, et al. Adult-onset opsoclonus-myoclonus syndrome. JAMA. Neurology. 2012;69:1598\u2013607.","journal-title":"Neurology"},{"key":"3012_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/1043454204272560","volume":"22","author":"ED Tate","year":"2005","unstructured":"Tate ED, Allison TJ, Pranzatelli MR, Verhulst SJ. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome. J Pediatr Oncol Nurs. 2005;22:8\u201319.","journal-title":"J Pediatr Oncol Nurs"},{"key":"3012_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1001\/jamaneurol.2015.4607","volume":"73","author":"T Armangu\u00e9","year":"2016","unstructured":"Armangu\u00e9 T, Sabater L, Torres-Vega E, Mart\u00ednez-Hern\u00e1ndez E, Ari\u00f1o H, Petit-Pedrol M, et al. Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies. JAMA Neurol. 2016;73:417\u201324.","journal-title":"JAMA Neurol"},{"key":"3012_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1055\/s-0029-1237723","volume":"40","author":"E de Grandis","year":"2009","unstructured":"de Grandis E, Parodi S, Conte M, Angelini P, Battaglia F, Gandolfo C, et al. Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome. Neuropediatrics. 2009;40:103\u201311.","journal-title":"Neuropediatrics"},{"key":"3012_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.2.437","volume-title":"Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus","author":"L Bataller","year":"2001","unstructured":"Bataller L, Graus F, Saiz A, Vilchez JJ. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. 2001."},{"key":"3012_CR6","first-page":"1","volume":"2019","author":"DC Nwafor","year":"2019","unstructured":"Nwafor DC, Petrone AB, Collins JM, Adcock AK. Paraneoplastic opsoclonus myoclonus in a patient with pancreatic adenocarcinoma. Case Rep Neurol Med. 2019;2019:1\u20133.","journal-title":"Case Rep Neurol Med"},{"key":"3012_CR7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1007\/s00415-006-0026-1","volume":"253","author":"KY Jung","year":"2006","unstructured":"Jung KY, Youn J, Chung CS. Opsoclonus-myoclonus syndrome in an adult with malignant melanoma [1]. J Neurol. 2006;253:942\u20133.","journal-title":"J Neurol"},{"key":"3012_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577570","volume":"355","author":"E Fonseca","year":"2021","unstructured":"Fonseca E, Varas R, Godoy-Sant\u00edn J, Valenzuela R, Sandoval P. Opsoclonus-myoclonus syndrome associated with anti Kelch-like protein-11 antibodies in a young female patient without cancer. J Neuroimmunol. 2021;355: 577570.","journal-title":"J Neuroimmunol"},{"key":"3012_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00415-019-09544-1","volume":"267","author":"A Vogrig","year":"2020","unstructured":"Vogrig A, Gigli GL, Segatti S, Corazza E, Marini A, Bernardini A, et al. Epidemiology of paraneoplastic neurological syndromes: a population-based study. J Neurol. 2020;267:26\u201335.","journal-title":"J Neurol"},{"key":"3012_CR10","doi-asserted-by":"publisher","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S, Antoine J-CG, Desestret V, Dubey D, et al. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflammation. 2021. https:\/\/doi.org\/10.1212\/NXI.0000000000001014.","DOI":"10.1212\/NXI.0000000000001014"},{"key":"3012_CR11","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","volume":"124","author":"F Graus","year":"2001","unstructured":"Graus F, Keime-Guibert F, Re\u00f1e R, Benyahia B, Ribalta T, Ascaso C, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124:1138\u201348.","journal-title":"Brain"},{"key":"3012_CR12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s11060-016-2266-y","volume":"130","author":"A D\u00edaz D\u00edaz","year":"2016","unstructured":"D\u00edaz D\u00edaz A, Herv\u00e1s Garcia M, Gonz\u00e1lez HA. Cerebellar dysfunction and spastic paraparesis associated to anti-Ri antibodies in a patient with a pancreatic neuroendocrine tumor. J Neurooncol. 2016;130:605\u20136.","journal-title":"J Neurooncol"},{"issue":"3","key":"3012_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1212\/01.wnl.0000196488.87746.7b","volume":"66","author":"L Hern\u00e1ndez-Echebarr\u00eda","year":"2006","unstructured":"Hern\u00e1ndez-Echebarr\u00eda L, Saiz A, Ar\u00e9s A, Tejada J, Garc\u00eda-Tu\u00f1\u00f3n L, Nieves C, et al. Paraneoplastic encephalomyelitis associated with pancreatic tumor and anti-GAD antibodies. Neurology. 2006;66(3):450\u20131.","journal-title":"Neurology."},{"key":"3012_CR14","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1007\/s00415-018-8970-0","volume":"265","author":"C Bost","year":"2018","unstructured":"Bost C, Chanson E, Picard G, Meyronet D, Mayeur ME, Ducray F, et al. Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies. J Neurol. 2018;265:2190\u2013200.","journal-title":"J Neurol"},{"key":"3012_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/ana.23917","volume":"75","author":"T Armangue","year":"2014","unstructured":"Armangue T, Titulaer MJ, Sabater L, Pardo-Moreno J, Gresa-Arribas N, Barbero-Bordallo N, et al. A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma. Ann Neurol. 2014;75:435\u201341.","journal-title":"Ann Neurol"},{"key":"3012_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/1570159X16666180917105033","volume":"17","author":"H Mitoma","year":"2019","unstructured":"Mitoma H, Manto M, Hampe CS. Immune-mediated cerebellar ataxias: practical guidelines and therapeutic challenges. Curr Neuropharmacol. 2019;17:33\u201358.","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"3012_CR17","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1212\/NXI.0000000000001153","volume":"9","author":"T Rossor","year":"2022","unstructured":"Rossor T, Yeh EA, Khakoo Y, Angelini P, Hemingway C, Irani SR, et al. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective. Neurol Neuroimmunol Neuroinflamm. 2022;9(3):1153.","journal-title":"Neurol Neuroimmunol Neuroinflamm."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-03012-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-03012-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-03012-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T04:29:47Z","timestamp":1672374587000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-03012-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3012"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-03012-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2022,12,30]]},"assertion":[{"value":"2 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patient to publish this case, and approval for this study was provided by the ethics committee of the University Hospital, Goethe University Frankfurt am Main.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient signed informed consent regarding publishing her data. A copy of the written consent is available for review by the editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"507"}}